CLOSE-Guided Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation: 1-Year Outcome.

CLOSE-guided ablation atrial fibrillation persistent atrial fibrillation pulmonary vein isolation single-procedure arrhythmia-free survival

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
15 Jul 2023
Historique:
received: 27 05 2023
revised: 23 06 2023
accepted: 09 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

CLOSE-guided pulmonary vein isolation (PVI) is based on contiguous and optimized (Ablation Index-guided) radiofrequency lesions. The efficacy of CLOSE-guided PVI in persistent atrial fibrillation (AF) treatment has been poorly evaluated. In two centers, 50 patients eligible for persistent AF ablation underwent CLOSE-guided PVI (Ablation Index ≥ 450 at the anterior wall, ≥300 at posterior wall, intertag distance ≤ 6 mm). If PVI failed to restore sinus rhythm (SR), electrical cardioversion (ECV) was performed. Atrial substrate modification (ASM) was performed only if PVI and ECV failed to restore SR. Recurrence was defined as any recorded episode of AF, atrial tachycardia (AT) or atrial flutter (AFL) > 30 s on Holter electrocardiographs at 3, 6 and 12 months. From the 50 patients (64 ± 10 years, 14% long-standing persistent AF), SR was restored by ECV in 34 patients (68%) 56 ± 38 days prior to ablation. On the day of ablation, 42 patients (84%) were on class I-III anti-arrhythmic drug therapy (ADT) and the rhythm was AF in 23/50 patients. PVI was achieved in all patients; after PVI, ECV was required in 21 patients and ASM in 1 patient. The mean procedure time, radiofrequency time and fluoroscopy time were 141 ± 33 min, 23 ± 7 min and 7 ± 6 min, respectively. At 12 months, single-procedure freedom from AF/AT/AFL was 80%, with 19 patients (38%) receiving class I-III ADT. In a population of patients with persistent AF monitored with intermittent cardiac rhythm recordings, CLOSE-guided PVI resulted in high single-procedure arrhythmia-free survival at 1 year. Future large-scale studies involving continuous cardiac monitoring are necessary.

Sections du résumé

BACKGROUND BACKGROUND
CLOSE-guided pulmonary vein isolation (PVI) is based on contiguous and optimized (Ablation Index-guided) radiofrequency lesions. The efficacy of CLOSE-guided PVI in persistent atrial fibrillation (AF) treatment has been poorly evaluated.
METHODS METHODS
In two centers, 50 patients eligible for persistent AF ablation underwent CLOSE-guided PVI (Ablation Index ≥ 450 at the anterior wall, ≥300 at posterior wall, intertag distance ≤ 6 mm). If PVI failed to restore sinus rhythm (SR), electrical cardioversion (ECV) was performed. Atrial substrate modification (ASM) was performed only if PVI and ECV failed to restore SR. Recurrence was defined as any recorded episode of AF, atrial tachycardia (AT) or atrial flutter (AFL) > 30 s on Holter electrocardiographs at 3, 6 and 12 months.
RESULTS RESULTS
From the 50 patients (64 ± 10 years, 14% long-standing persistent AF), SR was restored by ECV in 34 patients (68%) 56 ± 38 days prior to ablation. On the day of ablation, 42 patients (84%) were on class I-III anti-arrhythmic drug therapy (ADT) and the rhythm was AF in 23/50 patients. PVI was achieved in all patients; after PVI, ECV was required in 21 patients and ASM in 1 patient. The mean procedure time, radiofrequency time and fluoroscopy time were 141 ± 33 min, 23 ± 7 min and 7 ± 6 min, respectively. At 12 months, single-procedure freedom from AF/AT/AFL was 80%, with 19 patients (38%) receiving class I-III ADT.
CONCLUSIONS CONCLUSIONS
In a population of patients with persistent AF monitored with intermittent cardiac rhythm recordings, CLOSE-guided PVI resulted in high single-procedure arrhythmia-free survival at 1 year. Future large-scale studies involving continuous cardiac monitoring are necessary.

Identifiants

pubmed: 37510813
pii: jcm12144698
doi: 10.3390/jcm12144698
pmc: PMC10380439
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Europace. 2015 Oct;17(10):1596-600
pubmed: 26498718
J Cardiovasc Electrophysiol. 2009 Sep;20(9):1005-10
pubmed: 19493152
J Interv Card Electrophysiol. 2019 Jan;54(1):9-15
pubmed: 30058055
PLoS One. 2020 Jun 16;15(6):e0234461
pubmed: 32544209
Eur Heart J. 2018 Apr 21;39(16):1429-1437
pubmed: 29211857
J Cardiovasc Electrophysiol. 2020 Jul;31(7):1694-1701
pubmed: 32369225
Eur Heart J. 2017 May 01;38(17):1303-1316
pubmed: 28104790
Europace. 2018 Jan 1;20(1):33-42
pubmed: 28444307
Circ Arrhythm Electrophysiol. 2018 Sep;11(9):e006576
pubmed: 30354288
Europace. 2020 Nov 1;22(11):1645-1652
pubmed: 32879974
JACC Clin Electrophysiol. 2018 Jan;4(1):99-108
pubmed: 29600792
Circ Arrhythm Electrophysiol. 2015 Feb;8(1):18-24
pubmed: 25528745
J Am Coll Cardiol. 1997 Sep;30(3):791-8
pubmed: 9283542
Pacing Clin Electrophysiol. 2005 May;28(5):366-71
pubmed: 15869666
Eur Heart J. 2014 Jun 7;35(22):1466-78
pubmed: 24487524
J Am Coll Cardiol. 2012 Nov 6;60(19):1921-9
pubmed: 23062545
Heart Rhythm. 2021 Apr;18(4):529-537
pubmed: 33383226
Heart Rhythm. 2017 Oct;14(10):e275-e444
pubmed: 28506916
Pacing Clin Electrophysiol. 2014 Aug;37(8):1023-8
pubmed: 24665892
Circ Cardiovasc Interv. 2016 Apr;9(4):e003273
pubmed: 27072525
Europace. 2010 Feb;12(2):173-80
pubmed: 19889688
Europace. 2010 Sep;12(9):1211-2
pubmed: 20639207
J Cardiovasc Electrophysiol. 2020 Oct;31(10):2592-2599
pubmed: 32666561
JACC Clin Electrophysiol. 2018 Nov;4(11):1440-1447
pubmed: 30466850
Heart Rhythm. 2015 Jan;12(1):60-6
pubmed: 25281891
Europace. 2018 Nov 1;20(FI_3):f366-f376
pubmed: 29267853
Circulation. 2012 Aug 14;126(7):806-14
pubmed: 22824434
Circ Arrhythm Electrophysiol. 2016 Feb;9(2):e003596
pubmed: 26857909
J Cardiovasc Electrophysiol. 2005 Jul;16(7):801-3
pubmed: 16050843
JACC Clin Electrophysiol. 2022 Sep;8(9):1077-1089
pubmed: 36137711
Heart Rhythm. 2020 Nov;17(11):1841-1847
pubmed: 32590151
Circ Arrhythm Electrophysiol. 2017 Dec;10(12):
pubmed: 29217521
N Engl J Med. 2002 Dec 5;347(23):1825-33
pubmed: 12466506

Auteurs

Philippe Taghji (P)

Electrophysiology Unit, Cardiology Department, La Timone University Hospital, 13005 Marseille, France.

Jean-Claude Deharo (JC)

Electrophysiology Unit, Cardiology Department, La Timone University Hospital, 13005 Marseille, France.

Sana Amraoui (S)

Electrophysiology Unit, Cardiology Department, American Hospital of Paris, 92200 Neuilly-sur-Seine, France.

Sok-Sithikun Bun (SS)

Electrophysiology Unit, Cardiology Department, Pasteur University Hospital, 06000 Nice, France.

Classifications MeSH